4th Circ. Revives Purdue Pharma OxyContin FCA Row
The Fourth Circuit on Thursday revived a qui tam lawsuit accusing Purdue Pharma LP of violating the False Claims Act by falsely marketing painkiller OxyContin, vacating a lower court's ruling that...To view the full article, register now.
Already a subscriber? Click here to view full article